Relenza is a darn good drug. Don't discount it.
Inavir still smashed it.
End result. This great result for LANI makes me feel ill in light of the BARDA decision. We have a blockbuster drug. Will it ever get to market in the USA. Highly Unlikely as it stands today.
I'm lost for words.
Still holding and hoping for a hostile take over.
- Forums
- ASX - By Stock
- inavir sales
Relenza is a darn good drug. Don't discount it. Inavir still...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online